MIDKINE REPROGRAMS ANTI-TUMOR IMMUNITY AND PROMOTES IMMUNOTHERAPY RESISTANCE IN CANCER PATIENTS Contributor Nature Medicine Behind the paper MIDKINE REPROGRAMS ANTI-TUMOR IMMUNITY AND PROMOTES IMMUNOTHERAPY RESISTANCE IN CANCER PATIENTS Daniela Cerezo-Wallis Nov 09, 2020
